Biomarker discovery in human cerebrospinal fluid: The need for integrative metabolome and proteome databases

4Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The number of metabolites identified in human cerebrospinal fluid (CSF) has steadily increased over the past 5 years, and in this issue of Genome Medicine David Wishart and colleagues provide a comprehensive update that brings the number of metabolites listed in the CSF metabolome database to 476 compounds. There is now a need for an integrative metabolome-proteome CSF database to maximize the impact of this achievement in biomedical research. Only by such efforts can we hope to unravel the complexity of molecular pathophysiological processes. © 2012 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Schwarz, E., Torrey, E. F., Guest, P. C., & Bahn, S. (2012, April 30). Biomarker discovery in human cerebrospinal fluid: The need for integrative metabolome and proteome databases. Genome Medicine. https://doi.org/10.1186/gm338

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free